title: National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.
authors.forename: Andrew
authors.initials: A
authors.lastname: Tonkin
authors.forename: Philip
authors.initials: P
authors.lastname: Barter
authors.forename: James
authors.initials: J
authors.lastname: Best
authors.forename: Andrew
authors.initials: A
authors.lastname: Boyden
authors.forename: John
authors.initials: J
authors.lastname: Furler
authors.forename: Ken
authors.initials: K
authors.lastname: Hossack
authors.forename: David
authors.initials: D
authors.lastname: Sullivan
authors.forename: Peter
authors.initials: P
authors.lastname: Thompson
authors.forename: Margarite
authors.initials: M
authors.lastname: Vale
authors.forename: Catherine
authors.initials: C
authors.lastname: Cooper
authors.forename: Malia
authors.initials: M
authors.lastname: Robinson
authors.forename: Eleanor
authors.initials: E
authors.lastname: Clune
mesh_terms: D001053:Apolipoproteins / Q000097:blood; D001315:Australia; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008019:Life Style; D009520:New Zealand; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D014280:Triglycerides / Q000097:blood
chemical_list: D001053:Apolipoproteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014280:Triglycerides; D002784:Cholesterol